The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users

A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada

(2013) Bohdan Nosyk et al.   HEALTH AFFAIRS

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

(2013) Seyed-Moayed Alavian et al.   Hepatitis Monthly

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices

(2013) Catherine McGowan et al.   PLoS One

The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users

(2012) Julie Bruneau et al.   ADDICTION

Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study

(2012) Bohdan Nosyk et al.   ADDICTION

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

(2012) Peter Vickerman et al.   ADDICTION

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

Methadone Maintenance Therapy Outcomes in Iran

(2012) Roya Noori et al.   SUBSTANCE USE & MISUSE

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

(2011) Katy M. E. Turner et al.   ADDICTION

A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs

(2011) H. Hagan et al.   JOURNAL OF INFECTIOUS DISEASES

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

(2011) Paul K Nelson et al.   LANCET

Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities

(2010) Holly Hagan et al.   JOURNAL OF INFECTIOUS DISEASES

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed

(2010) Louisa Degenhardt et al.   LANCET

People who use drugs, HIV, and human rights

(2010) Ralf Jürgens et al.   LANCET

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

(2010) Bradley M Mathers et al.   LANCET

Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs

(2009) K. DeBeck et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience

(2009) Élise Roy et al.   DRUG AND ALCOHOL DEPENDENCE

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

(2009) N. CRAINE et al.   EPIDEMIOLOGY AND INFECTION

Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection

(2009) Kimberly Page et al.   JOURNAL OF INFECTIOUS DISEASES

Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users

(2008) Evan Wood   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION